Edgewise Therapeutics stock hits 52-week high at 36.71 - Investing.com
EWTX Stock | USD 29.46 0.78 2.58% |
Slightly above 68% of Edgewise Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Edgewise Therapeutics suggests that many traders are alarmed. Edgewise Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Edgewise Therapeutics' earnings reports, geopolitical events, and overall market trends.
Edgewise |
Edgewise Therapeutics stock hits 52-week high at 36.71 Investing.com
Read at news.google.com
Edgewise Therapeutics Current Investor Sentiment
Panic Vs Confidence
32
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Edgewise Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Edgewise Therapeutics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Edgewise Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Edgewise Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Edgewise Therapeutics Fundamental Analysis
We analyze Edgewise Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Edgewise Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Edgewise Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Edgewise Therapeutics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Edgewise Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Edgewise Therapeutics stock to make a market-neutral strategy. Peer analysis of Edgewise Therapeutics could also be used in its relative valuation, which is a method of valuing Edgewise Therapeutics by comparing valuation metrics with similar companies.
Peers
Edgewise Therapeutics Related Equities
CCCC | C4 Therapeutics | 2.86 | ||||
BDTX | Black Diamond | 2.09 | ||||
IKNA | Ikena Oncology | 1.80 | ||||
DSGN | Design Therapeutics | 1.69 | ||||
ACET | Adicet Bio | 0.95 | ||||
HOWL | Werewolf Therapeutics | 0.54 | ||||
RVMD | Revolution Medicines | 0.53 | ||||
PASG | Passage Bio | 0.38 | ||||
CELC | Celcuity LLC | 0.70 | ||||
XLO | Xilio Development | 0.93 | ||||
CGEM | Cullinan Oncology | 1.18 | ||||
MLYS | Mineralys Therapeutics, | 1.43 | ||||
ELYM | Eliem Therapeutics | 1.90 | ||||
VOR | Vor Biopharma | 2.88 | ||||
IPSC | Century Therapeutics | 4.08 |
Additional Tools for Edgewise Stock Analysis
When running Edgewise Therapeutics' price analysis, check to measure Edgewise Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edgewise Therapeutics is operating at the current time. Most of Edgewise Therapeutics' value examination focuses on studying past and present price action to predict the probability of Edgewise Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edgewise Therapeutics' price. Additionally, you may evaluate how the addition of Edgewise Therapeutics to your portfolios can decrease your overall portfolio volatility.